Michael E. Laurila

Small-Volume Continuous Manufacturing of Merestinib. Part 1. Process Development and Demonstration

Kevin P. Cole, Brandon J. Reizman, Molly Hess et al. · Organic Process Research & Development · 2019 · 50 citations

Pharmacy, Chemical Engineering, Manufacturing Engineering +17

Small-Volume Continuous Manufacturing of Merestinib. Part 2. Technology Transfer and cGMP Manufacturing

Brandon J. Reizman, Kevin P. Cole, Molly Hess et al. · Organic Process Research & Development · 2019 · 43 citations

Pharmacy, Chemical Engineering, Pharmaceutics +15

Optimized Catalytic Enantioselective Aryl Transfer Process Gives Access to mGlu2 Receptor Potentiators

Nicholas A. Magnus, Peter B. Anzeveno, Donald S. Coffey et al. · Organic Process Research & Development · 2007 · 42 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Process Development for a Key Synthetic Intermediate of LY2140023, a Clinical Candidate for the Treatment of Schizophrenia

Mario Waser, Eric D. Moher, Sandy S. K. Borders et al. · Organic Process Research & Development · 2011 · 40 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis of BACE Inhibitor LY2886721. Part II. Isoxazolidines as Precursors to Chiral Aminothiazines, Selective Peptide Coupling, and a Controlled Reactive Crystallization

Marvin M. Hansen, Daniel J. Jarmer, Enver Arslantas et al. · Organic Process Research & Development · 2015 · 29 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13